Siteman Cancer Center - Shiloh

Clinical research site in Shiloh, Illinois

Part of Siteman Cancer Center

As of July 2026, 2 paid clinical trials are recruiting at Siteman Cancer Center - Shiloh in Shiloh, Illinois. Active studies at this site cover conditions such as Advanced Hepatocellular Carcinoma, Advanced/Metastatic Urothelial Cancer and Carcinoma, Hepatocellular. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Siteman Cancer Center - Shiloh (2)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

74 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

for Carcinoma, Hepatocellular

29 locations incl. Los Angeles

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227012·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

More research sites in Shiloh

Explore more

Paid clinical trials in Shiloh, IL · Illinois clinical trials